(600422)"KPC PHARMACEUTICALS, INC."Announcement on Provision for Asset Impairment
Filed with SSE · Stock code 600422 · · 3 pages · Chinese
Summary by 6ix AI
The company reported specific amounts for bad debt provisions and inventory write-downs, emphasizing the cautious approach taken in evaluating potential impairment losses. The filing also includes the Audit and Risk Control Committee's approval of the impairment provisions, affirming compliance with accounting standards and the company's policies.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
KPC Pharmaceuticals, Inc. on 6ix
Story so far
Earlier from KPC Pharmaceuticals
- Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2026
- Announcement on Receipt of the Notice of Registration Acceptance from the National Association of Financial Market Institutional Investors
- Announcement on Convening the 2026 Semi-annual Performance Briefing
- Announcement on Amendments to the Articles of Association
- Announcement on Resolutions of the 21st Meeting of the 11th Board of Directors
Follow KPC Pharmaceuticals into a list and get an email when it puts out news.
Follow KPC Pharmaceuticals